Fc Gamma Receptor IIA (CD32A) R131 Polymorphism as a Marker of Genetic Susceptibility to Sepsis

Inflammation

Volumn 39, Issue 2, 2016, Pages 518-525

  Beppler, Jaqueline ^a   Koehler Santos, Patrícia ^b   Pasqualim, Gabriela ^b,d   Matte, Ursula ^b   Alho, Clarice Sampaio ^c   Dias, Fernando Suparregui ^c   Kowalski, Thayne Woycinck ^d   Velasco, Irineu Tadeu ^a   Monteiro, Renato C ^e   Pinheiro da Silva, Fabiano ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^e CNRS   (France)

Author keywords

biomarkers; critical care; genetic susceptibility; infection; inflammation

Indexed keywords

DNA; FC RECEPTOR IIA; FC RECEPTOR; FCGR2A PROTEIN, HUMAN; GENETIC MARKER;

ADULT; ALLELE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DNA SEQUENCE; FEMALE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; SEPTIC SHOCK; SINGLE NUCLEOTIDE POLYMORPHISM; CRITICAL ILLNESS; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; MICROBIOLOGY;

CRITICAL ILLNESS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IGG; SEPSIS;

EID: 84944931082     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-015-0275-1     Document Type: Article

References (69)

1. Martin, G.S., D.M. Mannino, S. Eaton, and M. Moss. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. The New England Journal of Medicine 348(16): 1546–54.
2. Hotchkiss, R.S., and I.E. Karl. 2003. The pathophysiology and treatment of sepsis. The New England Journal of Medicine 348(2): 138–50.
3. Holmes, C.L., J.A. Russell, and K.R. Walley. 2003. Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest 124(3): 1103–15.
4. Namath, A., and A.J. Patterson. 2009. Genetic polymorphisms in sepsis. Critical Care Clinics 25(4): 835–56. x.
5. Shimada, T., S. Oda, T. Sadahiro, M. Nakamura, Y. Hirayama, E. Watanabe, et al. 2011. Outcome prediction in sepsis combined use of genetic polymorphisms—a study in Japanese population. Cytokine 54(1): 79–84.
6. Sipahi, T., H. Pocan, and N. Akar. 2006. Effect of various genetic polymorphisms on the incidence and outcome of severe sepsis. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 12(1): 47–54.
7. Daeron, M. 1997. Fc receptor biology. Annual Review of Immunology 15: 203–34.
8. Guilliams, M., P. Bruhns, Y. Saeys, H. Hammad, and B.N. Lambrecht. 2014. The function of Fcgamma receptors in dendritic cells and macrophages. Nature Reviews Immunology 14(2): 94–108.
9. Raaz-Schrauder, D., A.B. Ekici, L.E. Munoz, L. Klinghammer, R.E. Voll, J.H. Leusen, et al. 2012. Patients with unstable angina pectoris show an increased frequency of the Fc gamma RIIa R131 allele. Autoimmunity 45(7): 556–64.
10. Warmerdam, P.A., J.G. van de Winkel, A. Vlug, N.A. Westerdaal, and P.J. Capel. 1991. A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. Journal of Immunology 147(4): 1338–43.
11. Salmon, J.E., J.C. Edberg, N.L. Brogle, and R.P. Kimberly. 1992. Allelic polymorphisms of human Fc gamma receptor IIA and Fc gamma receptor IIIB. Independent mechanisms for differences in human phagocyte function. The Journal of Clinical Investigation 89(4): 1274–81.
12. Zuniga, R., G.S. Markowitz, T. Arkachaisri, E.A. Imperatore, V.D. D’Agati, and J.E. Salmon. 2003. Identification of IgG subclasses and C-reactive protein in lupus nephritis: the relationship between the composition of immune deposits and FCgamma receptor type IIA alleles. Arthritis and Rheumatism 48(2): 460–70.
13. Bone, R.C., R.A. Balk, F.B. Cerra, R.P. Dellinger, A.M. Fein, W.A. Knaus, et al. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101(6): 1644–55.
14. Parra, F.C., R.C. Amado, J.R. Lambertucci, J. Rocha, C.M. Antunes, and S.D. Pena. 2003. Color and genomic ancestry in Brazilians. Proceedings of the National Academy of Sciences of the United States of America 100(1): 177–82.
15. Lahiri, D.K., and J.I. Nurnberger Jr. 1991. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Research 19(19): 5444.
16. Ahlgrimm, M., M. Pfreundschuh, M. Kreuz, E. Regitz, K.D. Preuss, and J. Bittenbring. 2011. The impact of Fc-gamma receptor polymorphisms in elderly patients with diffuse large B-cell lymphoma treated with CHOP with or without rituximab. Blood 118(17): 4657–62.
17. Brambila-Tapia, A.J., and I.P. Davalos-Rodriguez. 2009. Fcgamma receptor polymorphisms and systemic lupus erythematosus. Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 61(1): 66–72.
18. Tanaka, Y., Y. Suzuki, T. Tsuge, Y. Kanamaru, S. Horikoshi, R.C. Monteiro, et al. 2005. FcgammaRIIa-131R allele and FcgammaRIIIa-176V/V genotype are risk factors for progression of IgA nephropathy. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association—European Renal Association. 20(11): 2439–45.
19. Aksu, K., G. Kitapcioglu, G. Keser, A. Berdeli, G. Karabulut, S. Kobak, et al. 2008. FcgammaRIIa, IIIa and IIIb gene polymorphisms in Behcet’s disease: do they have any clinical implications? Clinical and Experimental Rheumatology 26(4 Suppl 50): S77–83.
20. Kobayashi, T., S. Ito, K. Yamamoto, H. Hasegawa, N. Sugita, T. Kuroda, et al. 2003. Risk of periodontitis in systemic lupus erythematosus is associated with Fcgamma receptor polymorphisms. Journal of Periodontology 74(3): 378–84.
21. van der Pol, W.L., M.D. Jansen, J.B. Kuks, M. de Baets, F.G. de Leppers-van Straat, J.H. Wokke, et al. 2003. Association of the Fc gamma receptor IIA-R/R131 genotype with myasthenia gravis in Dutch patients. Journal of Neuroimmunology 144(1–2): 143–7.
22. Suffredini, A.F., and S.J. Chanock. 2006. Genetic variation and the assessment of risk in septic patients. Intensive Care Medicine 32(11): 1679–80.
23. Sutherland, A.M., and K.R. Walley. 2009. Bench-to-bedside review: association of genetic variation with sepsis. Critical Care 13(2): 210.
24. Kumpf, O., and R.R. Schumann. 2008. Genetic influence on bloodstream infections and sepsis. International Journal of Antimicrobial Agents 32(Suppl 1): S44–50.
25. Chung, L.P., and G.W. Waterer. 2011. Genetic predisposition to respiratory infection and sepsis. Critical Reviews in Clinical Laboratory Sciences 48(5–6): 250–68.
26. Esposito, S., A. Zampiero, L. Pugni, S. Tabano, C. Pelucchi, B. Ghirardi, et al. 2014. Genetic polymorphisms and sepsis in premature neonates. PloS One 9(7), e101248.
27. Nachtigall, I., A. Tamarkin, S. Tafelski, A. Weimann, A. Rothbart, S. Heim, et al. 2014. Polymorphisms of the toll-like receptor 2 and 4 genes are associated with faster progression and a more severe course of sepsis in critically ill patients. The Journal of International Medical Research 42(1): 93–110.
28. Lin, Y.T., A. Verma, and C.P. Hodgkinson. 2012. Toll-like receptors and human disease: lessons from single nucleotide polymorphisms. Current Genomics 13(8): 633–45.
29. Yin, J., C.L. Yao, C.L. Liu, Z.J. Song, C.Y. Tong, and P.Z. Huang. 2012. Association of genetic variants in the IRAK-4 gene with susceptibility to severe sepsis. World Journal of Emergency Medicine 3(2): 123–7.
30. Toubiana, J., E. Courtine, F. Pene, V. Viallon, P. Asfar, C. Daubin, et al. 2010. IRAK1 functional genetic variant affects severity of septic shock. Critical Care Medicine 38(12): 2287–94.
31. Zhang, A.Q., W. Pan, J.W. Gao, C.L. Yue, L. Zeng, W. Gu, et al. 2014. Associations between interleukin-1 gene polymorphisms and sepsis risk: a meta-analysis. BMC Medical Genetics 15: 8.
32. Kornblit, B., L. Munthe-Fog, H.O. Madsen, J. Strom, L. Vindelov, and P. Garred. 2008. Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome. Critical Care 12(3): R83.
33. Kothari, N., J. Bogra, H. Abbas, M. Kohli, A. Malik, D. Kothari, et al. 2013. Tumor necrosis factor gene polymorphism results in high TNF level in sepsis and septic shock. Cytokine 61(2): 676–81.
34. Pappachan, J.V., T.G. Coulson, N.J. Child, D.J. Markham, S.M. Nour, M.C. Pulletz, et al. 2009. Mortality in adult intensive care patients with severe systemic inflammatory response syndromes is strongly associated with the hypo-immune TNF-238A polymorphism. Immunogenetics 61(10): 657–62.
35. Accardo Palumbo, A., G.I. Forte, D. Pileri, L. Vaccarino, F. Conte, L. D’Amelio, et al. 2012. Analysis of IL-6, IL-10 and IL-17 genetic polymorphisms as risk factors for sepsis development in burned patients. Burns: Journal of the International Society for Burn Injuries 38(2): 208–13.
36. Paskulin, D.D., P.R. Fallavena, F.J. Paludo, T.J. Borges, J.B. Picanco, F.S. Dias, et al. 2011. TNF-308G > a promoter polymorphism (rs1800629) and outcome from critical illness. The Brazilian Journal of Infectious Diseases: an Official Publication of the Brazilian Society of Infectious Diseases 15(3): 231–8.
37. Villar, J., L. Perez-Mendez, C. Flores, N. Maca-Meyer, E. Espinosa, A. Muriel, et al. 2007. A CXCL2 polymorphism is associated with better outcomes in patients with severe sepsis. Critical Care Medicine 35(10): 2292–7.
38. Thair, S.A., K.R. Walley, T.A. Nakada, M.K. McConechy, J.H. Boyd, H. Wellman, et al. 2011. A single nucleotide polymorphism in NF-kappaB inducing kinase is associated with mortality in septic shock. Journal of Immunology 186(4): 2321–8.
39. Huh, J.W., K. Song, J.S. Yum, S.B. Hong, C.M. Lim, and Y. Koh. 2009. Association of mannose-binding lectin-2 genotype and serum levels with prognosis of sepsis. Critical Care 13(6): R176.
40. Nakada, T.A., J.A. Russell, J.H. Boyd, R. Aguirre-Hernandez, K.R. Thain, S.A. Thair, et al. 2010. beta2-Adrenergic receptor gene polymorphism is associated with mortality in septic shock. American Journal of Respiratory and Critical Care Medicine 181(2): 143–9.
41. Benfield, T., K. Ejrnaes, K. Juul, C. Ostergaard, J. Helweg-Larsen, N. Weis, et al. 2010. Influence of factor V Leiden on susceptibility to and outcome from critical illness: a genetic association study. Critical Care 14(2): R28.
42. Zhang, A.Q., L. Zeng, W. Gu, L.Y. Zhang, J. Zhou, D.P. Jiang, et al. 2011. Clinical relevance of single nucleotide polymorphisms within the entire NLRP3 gene in patients with major blunt trauma. Critical Care 15(6): R280.
43. Henckaerts, L., K.R. Nielsen, R. Steffensen, K. Van Steen, C. Mathieu, A. Giulietti, et al. 2009. Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit. Critical Care Medicine 37(1): 192–201. e1-3.
44. Paludo, F.J., J.B. Picanco, P.R. Fallavena, R. Fraga Lda, P. Graebin, T. Nobrega Ode, et al. 2013. Higher frequency of septic shock in septic patients with the 47C allele (rs4880) of the SOD2 gene. Gene 517(1): 106–11.
45. Graebin, P., T.D. Veit, C.S. Alho, F.S. Dias, and J.A. Chies. 2012. Polymorphic variants in exon 8 at the 3’ UTR of the HLA-G gene are associated with septic shock in critically ill patients. Critical Care 16(5): R211.
46. Brookes, A.J. 1999. The essence of SNPs. Gene 234(2): 177–86.
47. LaRosa, S.P., and S.M. Opal. 2011. Biomarkers: the future. Critical Care Clinics 27(2): 407–19.
48. Vigato-Ferreira, I.C., J.E. Toller-Kawahisa, J.A. Pancoto, C.T. Mendes-Junior, E.Z. Martinez, E.A. Donadi, et al. 2014. FcgammaRIIa and FcgammaRIIIb polymorphisms and associations with clinical manifestations in systemic lupus erythematosus patients. Autoimmunity 47(7): 451–8.
49. Kangne, H.K., F.F. Jijina, Y.M. Italia, D.L. Jain, A.H. Nadkarni, M. Gupta, et al. 2013. The Fc receptor polymorphisms and expression of neutrophil activation markers in patients with sickle cell disease from western India. BioMedicine Research International 2013: 457656.
50. Bredius, R.G., B.H. Derkx, C.A. Fijen, T.P. de Wit, M. de Haas, R.S. Weening, et al. 1994. Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. The Journal of Infectious Diseases 170(4): 848–53.
51. Zhao, J., L. Ma, S. Chen, Y. Xie, L. Xie, Y. Deng, et al. 2014. Association between Fc-gamma receptor IIa (CD32) gene polymorphism and malaria susceptibility: a meta-analysis based on 6928 subjects. Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 23: 169–75.
52. Forthal, D.N., G. Landucci, J. Bream, L.P. Jacobson, T.B. Phan, and B. Montoya. 2007. FcgammaRIIa genotype predicts progression of HIV infection. Journal of Immunology 179(11): 7916–23.
53. Diamantopoulos, P.T., V. Kalotychou, K. Polonyfi, M. Sofotasiou, A. Anastasopoulou, A. Galanopoulos, et al. 2013. Correlation of Fc-gamma RIIA polymorphisms with latent Epstein-Barr virus infection and latent membrane protein 1 expression in patients with low grade B-cell lymphomas. Leukemia & Lymphoma 54(9): 2030–4.
54. Sole-Violan, J., M.I. Garcia-Laorden, J.A. Marcos-Ramos, F.R. de Castro, O. Rajas, L. Borderias, et al. 2011. The Fcgamma receptor IIA-H/H131 genotype is associated with bacteremia in pneumococcal community-acquired pneumonia. Critical Care Medicine 39(6): 1388–93.
55. Bougle, A., A. Max, N. Mongardon, D. Grimaldi, F. Pene, C. Rousseau, et al. 2012. Protective effects of FCGR2A polymorphism in invasive pneumococcal diseases. Chest 142(6): 1474–81.
56. Yuan, F.F., K. Marks, M. Wong, S. Watson, E. de Leon, P.B. McIntyre, et al. 2008. Clinical relevance of TLR2, TLR4, CD14 and FcgammaRIIA gene polymorphisms in Streptococcus pneumoniae infection. Immunology and Cell Biology 86(3): 268–70.
57. van Sorge, N.M., W.L. van der Pol, and J.G. van de Winkel. 2003. FcgammaR polymorphisms: implications for function, disease susceptibility and immunotherapy. Tissue Antigens 61(3): 189–202.
58. Shashidharamurthy, R., F. Zhang, A. Amano, A. Kamat, R. Panchanathan, D. Ezekwudo, et al. 2009. Dynamics of the interaction of human IgG subtype immune complexes with cells expressing R and H allelic forms of a low-affinity Fc gamma receptor CD32A. Journal of Immunology 183(12): 8216–24.
59. Pinheiro da Silva, F., M. Aloulou, D. Skurnik, M. Benhamou, A. Andremont, I.T. Velasco, et al. 2007. CD16 promotes Escherichia coli sepsis through an FcR gamma inhibitory pathway that prevents phagocytosis and facilitates inflammation. Nature Medicine 13(11): 1368–74.
60. Pasquier, B., P. Launay, Y. Kanamaru, I.C. Moura, S. Pfirsch, C. Ruffie, et al. 2005. Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM. Immunity 22(1): 31–42.
61. Pinheiro da Silva, F., M. Aloulou, M. Benhamou, and R.C. Monteiro. 2008. Inhibitory ITAMs: a matter of life and death. Trends in Immunology 29(8): 366–73.
62. Aloulou, M., S. Ben Mkaddem, M. Biarnes-Pelicot, T. Boussetta, H. Souchet, E. Rossato, et al. 2012. IgG1 and IVIg induce inhibitory ITAM signaling through FcgammaRIII controlling inflammatory responses. Blood 119(13): 3084–96.
63. Ben Mkaddem, S., G. Hayem, F. Jonsson, E. Rossato, E. Boedec, T. Boussetta, et al. 2014. Shifting FcgammaRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis. The Journal of Clinical Investigation 124(9): 3945–59.
64. Gershov, D., S. Kim, N. Brot, and K.B. Elkon. 2000. C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. The Journal of Experimental Medicine 192(9): 1353–64.
65. Schwedler, S.B., J.G. Filep, J. Galle, C. Wanner, and L.A. Potempa. 2006. C-reactive protein: a family of proteins to regulate cardiovascular function. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 47(2): 212–22.
66. Boncler, M., D. Dudzinska, J. Nowak, and C. Watala. 2012. Modified C-reactive protein selectively binds to immunoglobulins. Scandinavian Journal of Immunology 76(1): 1–10.
67. El Kebir, D., Y. Zhang, L.A. Potempa, Y. Wu, A. Fournier, and J.G. Filep. 2011. C-reactive protein-derived peptide 201–206 inhibits neutrophil adhesion to endothelial cells and platelets through CD32. Journal of Leukocyte Biology 90(6): 1167–75.
68. Aas, V., K.L. Sand, H.C. Asheim, H.B. Benestad, and J.G. Iversen. 2013. C-reactive protein triggers calcium signalling in human neutrophilic granulocytes via FcgammaRIIa in an allele-specific way. Scandinavian Journal of Immunology 77(6): 442–51.
69. Christaki, E., and E.J. Giamarellos-Bourboulis. 2014. The beginning of personalized medicine in sepsis: small steps to a bright future. Clinical Genetics 86(1): 56–61.